comparemela.com

Latest Breaking News On - Seracare life sciences inc - Page 7 : comparemela.com

Global In Vitro Diagnostics (IVD) Quality Control Industry (2020 to 2027) - Market Trajectory & Analytics

/PRNewswire/ The "In Vitro Diagnostics (IVD) Quality Control - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com s.

Australia
Japan
United-states
United-kingdom
Argentina
Brazil
China
Canada
Russia
Dublin
Ireland
Mexico

Insights on the Molecular Quality Controls Global Market to 2027 - Featuring Abbott Laboratories, Danaher and Qnostics Among Others

/PRNewswire/ The "Molecular Quality Controls - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com s offering. Amid the.

Germany
Maine
United-states
Japan
United-kingdom
China
Dublin
Ireland
Canada
France
Laura-wood
Helena-biosciences-europe

$926.6 Million Worldwide In Vitro Diagnostics (IVD) Quality Control Industry to 2027 - Impact of COVID-19 on the Market

Share: ResearchAndMarkets.com s offering. Amid the COVID-19 crisis, the global market for In Vitro Diagnostics (IVD) Quality Control estimated at US$926.6 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 3.8% over the analysis period 2020-2027. Immunochemistry, one of the segments analyzed in the report, is projected to record a 3.7% CAGR and reach US$423.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hematology segment is readjusted to a revised 4% CAGR for the next 7-year period.

Australia
Japan
United-states
United-kingdom
Argentina
Brazil
China
Canada
Russia
Dublin
Ireland
Mexico

Global Liquid Biopsy Market Review 2019-2020 and Forecast 2021-2025 with Profiles of Over 200 Competitors

Share this article Share this article ResearchAndMarkets.com s offering. The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted). Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising for the following liquid biopsy applications: noninvasive prenatal screening for average-risk populations; cancer screening and early detection; and recurrence monitoring for cancer patients. Biomarker types of most interest include cell-free DNA (cfDNA), circulating tumor cells (CTCs) and exosomes. Ongoing advances in sensitive molecular technologies such as next-generation DNA sequencing (NGS) and digital polymerase chain reaction (dPCR) enable the detection of biomarkers that are present

China
Amoy
Fujian
California
United-states
Dublin
Ireland
America
Diamir-bio
Cegat-gmbh
Pacific-biosciences
Cambridge-epigenetix

Protein Labeling Market Estimated to Grow at a CAGR of 12.3% During the Forecast Period 2020-2025

(+1) 614-588-8538 Protein Labeling Market Estimated to Grow at a CAGR of 12.3% During the Forecast Period 2020-2025 Growing Adoption of Molecular Biology Technique and Technological Advancement Are the Major Factors Driving the Growth of the Market. BriefingWire.com, 1/15/2021 - Protein Labeling Market size in 2019 is estimated to be $1.5 billion, growing at a CAGR of 12.3% during the forecast period 2020-2025.Proteins are the largest and most important biomolecules in a living organism, as they are vital to the functioning of an organism. Proteins are biotin labeled that are routinely detected or purified with avidin conjugates in many protein research applications. Growing adoption of molecular biology technique and technological advancement are the major factors driving the growth of the market. Moreover, increasing R&D expenditure and rise in the number of medical procedures and healthcare expenditure further enhance the overall market demand fo

United-states
America
Venkat-reddy
Us-environmental-protection-agency
Kaneka-corporation
Our-custom-research-services
Perkinelmer-inc
Merck-kga
Merck-kgaa
Thermo-fisher-scientific-inc
Seracare-life-sciences-inc
Promega-corporation

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.